Graybug Vision (GRAY) Competitors $1.72 -0.03 (-1.71%) As of 06/13/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock GRAY vs. CYCN, PHIO, AYTU, HCWB, LSB, ORGS, TLPH, CTXR, ADXN, and ACXPShould you be buying Graybug Vision stock or one of its competitors? The main competitors of Graybug Vision include Cyclerion Therapeutics (CYCN), Phio Pharmaceuticals (PHIO), Aytu BioPharma (AYTU), HCW Biologics (HCWB), Lakeshore Biopharma (LSB), Orgenesis (ORGS), Talphera (TLPH), Citius Pharmaceuticals (CTXR), Addex Therapeutics (ADXN), and Acurx Pharmaceuticals (ACXP). These companies are all part of the "pharmaceutical preparations" industry. Graybug Vision vs. Its Competitors Cyclerion Therapeutics Phio Pharmaceuticals Aytu BioPharma HCW Biologics Lakeshore Biopharma Orgenesis Talphera Citius Pharmaceuticals Addex Therapeutics Acurx Pharmaceuticals Cyclerion Therapeutics (NASDAQ:CYCN) and Graybug Vision (NASDAQ:GRAY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, dividends, valuation and risk. Which has higher earnings & valuation, CYCN or GRAY? Cyclerion Therapeutics has higher revenue and earnings than Graybug Vision. Cyclerion Therapeutics is trading at a lower price-to-earnings ratio than Graybug Vision, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCyclerion Therapeutics$2.08M4.80-$5.26M-$1.16-2.68Graybug VisionN/AN/A-$35.60M-$24.23-0.07 Does the MarketBeat Community prefer CYCN or GRAY? Cyclerion Therapeutics received 18 more outperform votes than Graybug Vision when rated by MarketBeat users. Likewise, 58.62% of users gave Cyclerion Therapeutics an outperform vote while only 50.00% of users gave Graybug Vision an outperform vote. CompanyUnderperformOutperformCyclerion TherapeuticsOutperform Votes3458.62% Underperform Votes2441.38% Graybug VisionOutperform Votes1650.00% Underperform Votes1650.00% Which has more risk and volatility, CYCN or GRAY? Cyclerion Therapeutics has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500. Comparatively, Graybug Vision has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Do insiders & institutionals hold more shares of CYCN or GRAY? 75.6% of Cyclerion Therapeutics shares are owned by institutional investors. Comparatively, 49.9% of Graybug Vision shares are owned by institutional investors. 34.3% of Cyclerion Therapeutics shares are owned by company insiders. Comparatively, 7.9% of Graybug Vision shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor CYCN or GRAY? In the previous week, Cyclerion Therapeutics had 1 more articles in the media than Graybug Vision. MarketBeat recorded 1 mentions for Cyclerion Therapeutics and 0 mentions for Graybug Vision. Cyclerion Therapeutics' average media sentiment score of 1.87 beat Graybug Vision's score of 0.00 indicating that Cyclerion Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Cyclerion Therapeutics Very Positive Graybug Vision Neutral Is CYCN or GRAY more profitable? Cyclerion Therapeutics' return on equity of -55.32% beat Graybug Vision's return on equity.Company Net Margins Return on Equity Return on Assets Cyclerion TherapeuticsN/A -55.32% -48.35% Graybug Vision N/A -77.61%-71.34% SummaryCyclerion Therapeutics beats Graybug Vision on 12 of the 13 factors compared between the two stocks. Get Graybug Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAY vs. The Competition Export to ExcelMetricGraybug VisionPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.70M$6.88B$5.57B$8.50BDividend YieldN/A2.48%5.27%4.17%P/E Ratio-0.998.4626.7519.66Price / SalesN/A261.91403.98152.07Price / CashN/A65.8538.2534.64Price / Book1.036.526.964.59Net Income-$35.60M$143.26M$3.23B$248.23M7 Day Performance-1.15%-0.21%-1.22%-1.07%1 Month Performance-10.09%10.62%6.34%2.59%1 Year Performance-64.75%3.63%33.05%13.50% Graybug Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRAYGraybug VisionN/A$1.72-1.7%N/A-65.9%$2.70MN/A-0.9927High Trading VolumeCYCNCyclerion Therapeutics1.6579 of 5 stars$3.12+5.4%N/A+14.3%$10.02M$2.08M-2.6930Gap DownPHIOPhio Pharmaceuticals3.9558 of 5 stars$2.06+0.5%$4.00+94.2%-64.1%$9.88MN/A-0.1910Short Interest ↓Gap UpAYTUAytu BioPharma1.4666 of 5 stars$1.59-10.7%N/A-31.8%$9.81M$81.66M-1.10160Short Interest ↓HCWBHCW Biologics3.4015 of 5 stars$6.80-5.7%$35.00+414.7%-87.8%$9.79M$1.45M-6.8040Analyst DowngradeShort Interest ↓Gap DownLSBLakeshore Biopharma0.6233 of 5 stars$1.05-1.9%N/AN/A$9.77M$672.27M0.00773ORGSOrgenesis1.5241 of 5 stars$2.03+4.2%N/AN/A$9.74M$662K0.00150Gap DownTLPHTalphera2.4298 of 5 stars$0.47-2.1%$5.00+968.4%-52.8%$9.60M$27K-0.6819Gap UpCTXRCitius Pharmaceuticals2.365 of 5 stars$0.88+14.7%$54.50+6,071.4%-94.4%$8.68MN/A0.0020Gap UpADXNAddex Therapeutics2.6742 of 5 stars$8.08-0.1%$30.00+271.3%-4.3%$8.57M$404.10K-23.7630Positive NewsACXPAcurx Pharmaceuticals3.2242 of 5 stars$0.36-5.6%$8.00+2,147.2%-87.4%$8.36MN/A-0.333Positive News Related Companies and Tools Related Companies CYCN Competitors PHIO Competitors AYTU Competitors HCWB Competitors LSB Competitors ORGS Competitors TLPH Competitors CTXR Competitors ADXN Competitors ACXP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAY) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graybug Vision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graybug Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRAY Stock Free GRAY Stock Alerts